Applied Finance Capital Management LLC Invests $287,000 in Universal Health Services, Inc. $UHS

Key Points

• Applied Finance Capital Management LLC invested approximately $287,000 in Universal Health Services, acquiring 1,582 shares in the second quarter.
• Universal Health Services reported a quarterly EPS of $5.35, exceeding analysts' estimates by $0.50, with revenue of $4.28 billion.
• The current consensus price target for Universal Health Services is $218.69, with a mix of ratings from analysts including four Buy and one Sell rating.

Applied Finance Capital Management LLC acquired a new position in Universal Health Services, Inc. (NYSE:UHS - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,582 shares of the health services provider's stock, valued at approximately $287,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Invesco Ltd. increased its position in shares of Universal Health Services by 6.0% during the first quarter. Invesco Ltd. now owns 1,315,468 shares of the health services provider's stock valued at $247,176,000 after acquiring an additional 74,128 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Universal Health Services by 9.0% during the first quarter. Dimensional Fund Advisors LP now owns 1,241,738 shares of the health services provider's stock valued at $233,311,000 after acquiring an additional 102,137 shares during the last quarter. AQR Capital Management LLC increased its position in shares of Universal Health Services by 57.8% during the first quarter. AQR Capital Management LLC now owns 931,355 shares of the health services provider's stock valued at $173,381,000 after acquiring an additional 340,966 shares during the last quarter. American Century Companies Inc. increased its position in shares of Universal Health Services by 1.7% during the first quarter. American Century Companies Inc. now owns 634,592 shares of the health services provider's stock valued at $119,240,000 after acquiring an additional 10,449 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of Universal Health Services by 3.5% during the first quarter. Bank of New York Mellon Corp now owns 504,804 shares of the health services provider's stock valued at $94,853,000 after acquiring an additional 16,900 shares during the last quarter. 86.05% of the stock is owned by hedge funds and other institutional investors.

Universal Health Services Price Performance

Universal Health Services stock opened at $204.48 on Friday. Universal Health Services, Inc. has a one year low of $152.33 and a one year high of $240.26. The business has a fifty day moving average price of $191.08 and a 200-day moving average price of $182.34. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.29 and a quick ratio of 1.19. The firm has a market capitalization of $13.01 billion, a P/E ratio of 10.77, a PEG ratio of 0.84 and a beta of 1.30.

Universal Health Services (NYSE:UHS - Get Free Report) last posted its quarterly earnings results on Monday, July 28th. The health services provider reported $5.35 EPS for the quarter, topping analysts' consensus estimates of $4.85 by $0.50. Universal Health Services had a return on equity of 18.25% and a net margin of 7.66%.The firm had revenue of $4.28 billion during the quarter, compared to analyst estimates of $4.24 billion. During the same period last year, the company earned $4.31 earnings per share. The business's revenue for the quarter was up 9.6% on a year-over-year basis. Universal Health Services has set its FY 2025 guidance at 20.000-21.000 EPS. As a group, equities research analysts forecast that Universal Health Services, Inc. will post 15.92 EPS for the current year.

Analyst Upgrades and Downgrades

UHS has been the subject of a number of research analyst reports. JPMorgan Chase & Co. decreased their price target on Universal Health Services from $215.00 to $195.00 and set a "neutral" rating for the company in a research report on Monday, August 4th. UBS Group set a $227.00 price target on Universal Health Services in a research report on Wednesday, July 30th. Robert W. Baird decreased their price target on Universal Health Services from $243.00 to $203.00 and set a "neutral" rating for the company in a research report on Thursday, August 14th. Wells Fargo & Company raised their target price on Universal Health Services from $210.00 to $249.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 7th. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of Universal Health Services in a research report on Wednesday, October 8th. Four investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Universal Health Services currently has an average rating of "Hold" and a consensus price target of $218.69.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.